Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer [Urologic Oncology]

Conclusion
PSA levels in midlife strongly predict future lethal PCa in a US cohort subject to opportunistic screening. Risk-stratified screening on the basis of midlife PSA should be considered in men age 45 to 59 years.

Source: Journal of Clinical Oncology - August 2, 2016 Category: Cancer & Oncology Authors: Preston, Batista, Wilson, Carlsson, Gerke, Sjoberg, Dahl, Sesso, Feldman, Gann, Kibel, Vickers, Mucci Tags: Epidemiology & Prevention Urologic Oncology Source Type: research